Sample Report Access Source https://www.mrrse.com/sample/4357
The global IBD treatment market is projected to be primarily driven by the new product development and approvals, rising use of biologic drugs and biosimilar drugs for the treatment of IBD. The high prevalence and increasing incidence of Crohn’s disease and Ulcerative colitis disease in developed countries has fueled the development of novel therapeutics drugs. Genetic factors are found to induce the one of the forms of IBD. The children of parents having IBD are more likely to develop the symptoms of IBD. Studies have shown that around 5 to 20 % of affected population have developed the symptoms of IBD through inherited genes from parents. The Risk of developing IBD is higher when both the parents are affected with IBD. Biopharmaceutical companies have made the significant investments in R&D activities and there are large number of pipeline products in different stages of clinical approvals which are likely to commercialize during the forecast period. Recent launch and approvals of new drugs in North America and Europe as well as in Japan is projected to fuel the demand for IBD treatment drugs in near future.
The global IBD treatment market is broadly categorized into four segments based on drug class, disease indication, distribution channel and region. By drug class, the global market is segmented into TNF inhibitors, aminosalicyclates, immunomodulators, and corticosteroids. The TNF inhibitors accounted for leading share of global IBD treatment market in 2016 and is projected to gain its market share by the end of 2025. The large share and growth of TNF inhibitors is attributed to rising use of biologic drugs as second line of treatment and approvals in key markets. Aminosalicyclates drug class is the second leading share holder of global IBD treatment market and is projected to substantially lose its market share to corticosteroids and immunomodulators during the forecast period. In terms of distribution channel, the global IBD treatment market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.
By geography, the global IBD treatment market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. These regions have been further segmented by countries, drug class, and disease indication and distribution channels. North America and Europe accounted for leading share of global IBD treatment market and are projected to gain the market share by the end of 2025.
Global Inflammatory Bowel Disease (IBD) Treatment Market: Competitive Outlook k
The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the global inflammatory bowel disease treatment market. The report also profiles major players in the market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Major players operating in the inflammatory bowel disease treatment market include Shire Plc., Valeant Pharmaceuticals International, Inc., Allergan plc, Pfizer, Inc., Janssen Biotech, Inc. (Johnson & Johnson), Takeda Pharmaceutical Company Limited., AbbVie, Inc., Novartis AG, UCB Inc., and Biogen Inc.
Acquire Fully-Loaded Research Reports https://www.mrrse.com/inflammatory-bowel-disease
Global Inflammatory Bowel Disease Treatment Market is segmented as given below:
Global Inflammatory Bowel Disease Treatment Market, by Drug Class
- TNF Inhibitors
Global Inflammatory Bowel Disease Treatment Market, by Disease Indication
- Ulcerative Colitis
- Crohn’s Disease
Global Inflammatory Bowel Disease Treatment Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Inflammatory Bowel Disease Treatment Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Request for Information Procurement https://www.mrrse.com/enquiry/4357
About Market Research Reports Search Engine (MRRSE)
Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY - 12207
United States Telephone: +1-518-730-0559